Form 4: Agios Pharmaceuticals Executive Sells Shares

Theodore James Jr. Washburn, Principal Accounting Officer at Agios Pharmaceuticals, sold 772 shares of common stock at $56.09 per share.

Summary

• Theodore James Jr. Washburn, the Principal Accounting Officer of Agios Pharmaceuticals, sold 772 shares of the company's common stock on November 8, 2024.
• The shares were sold at a price of $56.09 per share.
• Following the transaction, Mr. Washburn still beneficially owns 813 shares purchased through the company's employee stock purchase plan.

Sentiment

Score: 5

Explanation: This is a neutral event, as it is a routine filing for an executive stock sale. It doesn't indicate a positive or negative outlook for the company.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the transactions of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The sale of shares by an executive is a common occurrence and does not necessarily indicate a negative outlook for the company.

Stakeholder Impact

• This transaction provides transparency to shareholders regarding insider trading activity.

Key Dates

Keywords

Agios Pharmaceuticals, insider trading, stock sale, Form 4, executive, AGIO, equity securities